Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae

New England Journal of Medicine

Volumn 354, Issue 14, 2006, Pages 1455-1463

  Kyaw, Moe H ^a   Lynfield, Ruth ^b   Schaffner, William ^c   Craig, Allen S ^d   Hadler, James ^e   Reingold, Arthur ^f   Thomas, Ann R ^g   Harrison, Lee H ^h   Bennett, Nancy M ^i,j   Farley, Monica M ^k,l   Facklam, Richard R ^a   Jorgensen, James H ^m   Besser, John ^b   Zell, Elizabeth R ^a   Schuchat, Anne ^a   Whitney, Cynthia G ^a,n  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b MINNESOTA DEPARTMENT OF HEALTH   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TENNESSEE DEPARTMENT OF HEALTH   (United States)

^e CDC   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g OREGON DEPARTMENT OF HUMAN SERVICES   (United States)

^h JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ Monroe County Department of Public Health   (United States)

^j UNIVERSITY OF ROCHESTER   (United States)

^k EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l VETERANS AFFAIRS MEDICAL CENTER   (United States)

^m UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

ⁿ CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; GROUPS BY AGE; HUMAN; INCIDENCE; INFANT; INFECTION CONTROL; INFECTION RATE; MAJOR CLINICAL STUDY; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; SEROTYPING; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; HUMANS; INFANT; MENINGOCOCCAL VACCINES; MIDDLE AGED; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POPULATION SURVEILLANCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 33645505114     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa051642     Document Type: Article

References (25)

1. Schrag SJ, Beall B, Dowell SF. Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions. Clin Microbiol Rev 2000;13:588-601.
2. Whitney CG, Farley MM, Hadler J, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000;343:1917-24.
3. McCormick AW, Whitney CG, Farley MM, et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med 2003;9:424-30.
4. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000;49(RR-9):1-35.
5. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of proteinpolysaccharide conjugate vaccine. N Engl J Med 2003;348:1737-46.
6. Talbot TR, Poehling KA, Hartert TV, et al. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 2004;39:641-8.
7. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: fourteenth informational supplement. Wayne, Pa.: NCCLS, 2004. (NCCLS document M100-S14.)
8. Kaplan SL, Mason EO Jr, Wald ER, et al. Decrease of invasive pneumococcal infections among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 2004;113:443-9.
9. Pelton SI, Loughlin AM, Marchant CD. Seven valent pneumococcal conjugate vacine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates. Pediatr Infect Dis J 2004;23:1015-22.
10. National, state, and urban area vaccination coverage among children aged 19-35 months - United States, 2004. MMWR Morb Mortal Wkly Rep 2005;54:717-21.
11. Hendley JO, Sande MA, Stewart PM, Gwaltney MJ Jr. Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis 1975;132:55-61.
12. Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal disease. N Engl J Med 2000;342:681-9.
13. Givon-Lavi N, Fraser D, Dagan R. Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings. Pediatr Infect Dis J 2003;22:524-32.
14. Influenza and pneumococcal vaccination levels among persons aged > or = 65 years - United States, 1999. MMWR Morb Mortal Wkly Rep 2001;50:532-7.
15. Influenza and pneumococcal vaccination coverage among persons aged > or = 65 years and persons aged 18-64 years with diabetes or asthma - United States, 2003. MMWR Morb Mortal Wkly Rep 2004;53:1007-12. [Erratum, MMWR Morb Mortal Wkly Rep 2005;54:935.]
16. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001;344:403-9.
17. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000;19:187-95.
18. Klugman KP, Madhi SA, Huebner RE, et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003;349:1341-8.
19. Kilpi T, Ahman H, Jokinen J, et al. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis 2003;37:1155-64.
20. Hausdorff WP, Yothers G, Dagan R, et al. Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J 2002;21:1008-16.
21. Dagan R, Givon-Lavi N, Zamir O, Fraser D. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers. Pediatr Infect Dis J 2003;22:532-40.
22. Pneumococcal infections. In: Pickering LK, Baker CJ, Overturf GD, et al., eds. 2003 Red book: report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, Ill.: American Academy of Pediatrics, 2003:490-500.
23. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39:1267-84.
24. Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 2004;113:1451-65.
25. Mandell LA, Bartlett JG, Dowell SF, et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003;37:1405-33.